Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial

Bibliographic Details
Title: Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial
Authors: Anderson, Anna, Ang, Mary, Barnes, Timothy, Bassin, Michelle, Bessey, Kate, Bowler, Simon, Bull, Sheetal, Burr, Lucy, Burton, Robert, Byrne, Michelle, Carroll, Robert, Chee, Nicholas, Choy, Aaron, Clark, Malcolm, Dalebout, Marije, De Wet, Peter, Deshmukh, Kshama, Diez Alvarez, Sergio, Douglas, Dominic, Engelander, Jacqueline, Evangelista, Carla, Game, Stuart, Glass, Noor, Gunner, Elizabeth, Han, Jennifer, Harrison, Michael, Hing Kiang, Jason Doong, Hlaing, Thazin, Joshi, Divyansh, Joyce, Sheree, Kaluhin, Karen, Kavic, Milanka, Kononov, Juliana, Lee, Gary, Lee, Wei-I, Leelasena, Indika, Leong, Esmond, Lim, Ivan, Lister, Graham, Loh, Denissa, Magdy, Mary, Maggs, Callum, Mammoottil, Amith, McCarthy, Shannon, McKay, Nicole, Melek, Mariah, Michael Barnett, Adrian, Mohan, Rahul, Moore, Andrew, Moore, Amanda, Murdoch, Louise, Napier-Flood, Fiona, Narsai, Ushma, Neville, Alexander, Nguyen, Paul, Odarchenko, Ekaterina, Pardey, Toni, Quan, Dick, Ranagsinghe, Ushank, Rasalam, Roy, Rayar, Shiva, Ruthnam, Gonasagaran Jay, Seet, Pi, Smith, Deon, Srilakshmanan, Krishna, Taggart, Angela, Tiong, Florence, Toh, Boon, Ujvary, Eniko, Wallace, Stephanie, Wolf, Rebecca, Wong, Ian, Yoo, Hye, Young, Rhys, Bennett, Chijioke *, Woo, Wayne, Bloch, Mark, Cheung, King, Griffin, Paul, Deshmukh, Sachin, Arya, Mark, Cumming, Oscar, Neville, A Munro, McCallum Pardey, Toni G, Plested, Joyce S, Cloney-Clark, Shane, Zhu, Mingzhu, Kalkeri, Raj, Patel, Nita, Marcheschi, Alex, Swan, Jennifer, Smith, Gale, Cho, Iksung, Glenn, Gregory M, Walker, Robert, Mallory, Raburn M
Source: In The Lancet Infectious Diseases June 2024 24(6):581-593
Database: ScienceDirect
More Details
ISSN:14733099
DOI:10.1016/S1473-3099(24)00077-X
Published in:The Lancet Infectious Diseases
Language:English